The #1-prescribed NSAID (ibuprofen)1 with the convenience
of built-in gastroprotection (famotidine)
DUEXIS, a combination of the NSAID
ibuprofen and the histamine H2-receptor
antagonist famotidine, is indicated for:
- The relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer, in patients who are taking ibuprofen for those indications
- The clinical trials primarily enrolled patients less than 65 years of age* without a prior history of GI ulcer. Controlled trials do not extend beyond 6 months.
*In clinical trials of DUEXIS, 18% of patients were
65 years of age or older.2
DUEXIS is designed to help you control the pain and inflammation of osteoarthritis and rheumatoid arthritis
TID dosing provides
2400 mg of ibuprofen and
80 mg of famotidine.